Evaluation of modified hodge test as an indicator of klebsiella pneumoniae carbapenemase (KPC) production by using bla kpc gene PCR by Priyadarshini Shanmugam, Nirupa Soundararajan, Jeya Meenakshisundaram
65
Priyadarshini et al., Int J Med Res Health Sci.2014;3(1):65-70
International Journal of Medical Research
&
Health Sciences
www.ijmrhs.com Volume 3 Issue 1 (Jan- Mar) Coden: IJMRHS Copyright @2013 ISSN: 2319-5886
Received: 31
st Oct 2013 Revised: 14
th Nov 2013 Accepted: 18
th Nov 2013
Research article
EVALUATION OF MODIFIED HODGE TEST AS AN INDICATOR OF KLEBSIELLA PNEUMONIAE
CARBAPENEMASE (KPC) PRODUCTION BY USING bla KPC GENE PCR
*Priyadarshini Shanmugam, Nirupa Soundararajan, Jeya Meenakshisundaram
Department of Microbiology, Chettinad Hospital and Research Institute, Tamilnadu, India
*Corresponding author email: priyadarshini0018@gmail.com
ABSTRACT
Introduction: Carbapenems belong to the Beta Lactam group of antimicrobial agents. They are often used as “last-
line agents” or “antibiotics of last resort” in critically ill patients. Carbapenem resistance in Enterobacteriaceae may
be due to various reasons but Klebsiella pneumoniae Carbapenemase (KPC) enzyme production is the commonest.
Phenotypic as well as genotypic methods can be used to detect Carbapenemases. Among the phenotypic tests,
Modified Hodge Test (MHT) is relatively easy to perform. Aims and Objectives: This study aimed to determine
the prevalence of carbapenem resistance among Enterobacteriaceae isolates and calculate the sensitivity of MHT as
an indicator of KPC production. Materials and Methods: All Enterobacteriaceae isolates from clinical samples
were  included  in  this  study  and  were screened  for  Carbapenem  resistance.  45  randomly  chosen  Carbapenem
Resistant Enterobacteriaceae isolates were subjected to MHT and blaKPC gene detection by PCR. Results: 2035
Enterobacteriaceae isolates were tested and 5.2% were found to be resistant to Imipenem, 22.9 % were resistant to
Meropenem and 4.42 % were resistant to both Imipenem and Meropenem. The sensitivity of MHT was calculated to
be 90% and specificity was calculated to be 60%
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INTRODUCTION
Bacteria  belonging  to the Enterobacteriaceae family
are normally  present  as  harmless  human  gut flora.
These bacteria are the leading cause of a wide range of
opportunistic infections.
1 Carbapenems belongs to the
Beta Lactam group of antimicrobial agents, which kill
bacteria by inhibiting the bacterial cell wall synthesis.
2
They possess  the  broadest  spectrum  of  activity  and
greatest  potency  against  Gram-positive  and  Gram-
negative bacteria.
3 As a result, they are often used as
“last-line agents” or “antibiotics of last resort” when
patients  with  infections  become  gravely  ill  or  are
suspected of harboring resistant bacteria.
3 Carbapenem
resistance  among Enterobacteriaceae members  is  of
great concern as these bacteria are easily transmissible
among patients, leading to hospital acquired infections
(HAI),  but  can  also  spread  into  the  community,
resulting in community acquired cases.
1
Carbapenem resistance in Enterobacteriaceae may be
due to various reasons that include hyper production of
the Amp C beta lactamase, loss of porins, production
of metallo beta lactamases (MBL) and production of K
pneumonia carbapenemases.
1
Carbapenemases  increasingly  have  been  reported
worldwide in Enterobacteriaceae in  the  past  10
years.
4, 5 A large variety of carbapenemases has been
identified in Enterobacteriaceae belonging to 3 classes
of  β-lactamases:  the  Ambler  class  A,  B,  and  D  β-
lactamases.
3 In  addition,  rare  chromosome  encoded
cephalosporinases  (Ambler  class  C)  produced  by
Enterobacteriaceae may  possess  slight  extended
DOI: 10.5958/j.2319-5886.3.1.01366
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activity toward carbapenems.
4 Their identification is of
primary  importance  since  carbapenemase  producers
are resistant not only to most Beta-lactams but also to
other main classes of antibiotics.
5
Carbapenemases  can  be  detected  by  phenotypic  as
well  as  genotypic  methods.
6 Modified Hodge Test
(MHT) is  a phenotypic  method  which  is relatively
simple  and  easy  to perform in  a  laboratory.
6 This
cloverleaf technique, or Modified Hodge test, has been
extensively used  as  a  phenotypic  technique  for
detecting carbapenemase activity.
5
Limitations  of  the MHT  in  terms  of  clinical
performance are its lack of specificity and the delay in
obtaining the results upto 24 or 48 hours after isolation
of  a  bacterial  colony.
5 The  molecular  detection  of
blaKPC is  the  gold  standard  for  diagnosis,  but  the
majority of laboratories in our country does not have
the resources necessary to perform this test.
7
The aim of this study was to determine the prevalence
of  Carbapenem  resistance  among  Enterobacteriaceae
and  detect  the  bla KPC gene  prevalence  among
randomly  chosen  Carbapenem  resistant
Enterobacteriaceae  clinical  isolates  in  our  750  bed
hospital. The  study  also  aimed to evaluate  the
performance of the Modified Hodge test and calculate
the sensitivity of MHT as an indicator of Klebsiella
Pneumoniae Carbapenemase (KPC) production.
MATERIALS AND METHODS
The isolates in this study were collected in a period of
one year from July 2012 to June 2013. The study was
conducted at  Chettinad  Hospital  and  Research
Institute, Chennai. The institutional ethical committee
approval was obtained prior to commencement of this
study. All  Enterobacteriaceae  isolates  from  clinical
samples like pus, wound swab, sputum, endotracheal
aspirate, blood and urine were included in this study.
The samples were collected after obtaining informed
consent from the patients. For evaluation of Modified
Hodge Test by PCR, 45 isolates which were resistant
to  both  or  either  Imipenem  or  Meropenem  were
randomly  selected.  MHT  and  bla KPC PCR  were
performed on these 45 isolates
These  isolates  were screened  for  Carbapenem
resistance  in  addition  to  the  routine  antibiotic
susceptibility  testing,  which was  performed  by the
Kirby Bauer method, as per the CLSI guidelines 2012.
8 Antimicrobial  discs  used  were  Ampicillin (10μg),
Gentamicin (10μg),  Amikacin (30μg),  Cefazolin  (30
μg),  Cefuroxime (30μg) Ceftazidime (30μg),
Cefotaxime (30μg),  Ceftriaxone (30μg),  Cefepime
(30μg),  Ciprofloxacin  (5μg),  Cotrimoxazole
(23.75/1.25μg), Piperacillin/ tazobactam  (100/10μg),
Imipenem (10μg), Meropenem (10 µg), Polymyxin B
(300 units) and Colistin (10µg).
Modified Hodge Test
Phenotypic  detection  of Carbapenemase  production
was done by using the Modified Hodge test. This test
was performed as per the CLSI guidelines 2012.
8 A
0.5 Mac Farland’s suspension of ATCC Escherichia
coli 25922 was diluted 1:10 in sterile saline. This was
inoculated on a Mueller Hinton agar plate, as for the
routine disc diffusion testing. The plate was dried for 5
minutes and a disc of Imipenem 10 μg was placed in
the centre of the agar plate. 3-5 colonies of the test
organism were picked and inoculated in a straight line,
from the edge of the disc, up to a distance of at least
20mm. The plates were incubated at 37
0C overnight
and they were examined next day. They were checked
for an enhanced growth around the test organism, at
the intersection of the streak and for a zone of inhibi-
tion. The  presence  of  an enhanced  growth indicated
Carbapenemase  production,  and  the  absence  of  an
enhanced  growth  meant  that  the  test  isolate did  not
produce carbapenemase.
8
bla KPC gene detection
The  isolates  which  gave  positive  results  for  the
modified  Hodge  test  were  submitted  to  molecular
detection of the bla KPC gene by PCR. The PCR Kits
were  procured  from  Helini  Biomolecules,  Chennai.
Isolates with negative test results were also randomly
chosen for PCR. The Polymerase Chain Reaction was
set up in a PCR vial, after adding the master mix, the
forward and reverse primers and the extracted DNA
from  the  isolates. The  primers  used for  PCR
amplification  and  the  reaction  conditions  were
Forward Primer: 5’-GCT CAG GCG CAA CTG TAA
G-3’ Reverse Primer: 5’-AGC ACA GCG GCA GCA
AGA  AAG-3’. The  PCR  vial  was  placed in  PCR
machine (Corpect Research 96 wells, Australia) and it
was subjected to initial denaturation at 94ºC for 3 min,
followed by 30 cycles of denaturation at 94ºC for 1
minute, annealing at 60ºC for 1minute and extension at
72ºC  for  1minute.  A  final  extension  procedure  was
carried out at 72º C for 5 min. Next the PCR products
were subjected to electrophoresis on 2% agarose gel
stained with ethidium bromide and visualized with UV67
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light The  antibiogram for  the  Carbapenem  Resistant
Enterobacteriaceae was analyzed
RESULTS
2035  non  repetitive  isolates  of  Enterobacteriaceae
were obtained from clinical samples such as pus, urine,
blood,  sputum  and  endotracheal  aspirates,  over  a
period  of  1  year. Of  these,  1178  (57.88%)  were
Escherichia coli, 444 (21.81) were Klebsiella species,
178 (8.7%) Proteus species, 154 (7.56%) Citrobacter
species and 81  (3.9%)  were Enterobacter isolates
(Figure1). Figure 2 shows the number of carbapenem
resistant  isolates  among  the  individual  genera.  The
antibiogram of  the  Enterobacteriaceae isolates  is
tabulated  in  Table  1  and  the  antibiotic  resistance
pattern of the CRE are tabulated in Table 2.
Of the total of 2035 isolates, 106 (5.2%) were resistant
to  Imipenem  and  468  (22.9  %)  were  resistant  to
Meropenem  and  90  (4.42  %)  were  resistant to  both
Imipenem and Meropenem.
Fig 1: Total number of Enterobacteriaceae isolates Fig 2: Carbapenem Resistance pattern of the Isolates
Table 1: Antibiotic Resistance pattern of the Enterobacteriaceae (% of Resistance)
ANTIBIOTIC Ecoli Klebsiella Proteus Citrobacter Enterobacter
Amikacin 9.67 % 16.64 % 31.46 % 16.88 % 11.11 %
Ampicillin 85.7 % 100 % 71.51% 88.42 % 69.14 %
Cefazolin 71.3% 66.67 % 82.58 % 72.73 % 82.72 %
Cefuroxime 64.9 % 59.46 % 66.83 % 58.44 % 65.43 %
Cefotaxime 61.1 % 53.38 % 49.43 % 51.3 % 46.91 %
Cefepime 53.2 % 42.79 % 39.32 % 37.66 % 38.27 %
Ciprofloxacin 63.1 % 47.07 % 58.99 % 40.26 % 41.98 %
Cotirmox 55.2 % 50.9 % 68.02 % 46.75 % 45.68 %
Colistin 0 % 0 % 100 % 2.6 % 0 %
Genta 36.76 % 34.0 %1 46.07 % 34.42 % 32.1 %
Imipenem 3.23 % 9.68 % 6.82 % 5.84 % 4.94 %
Meropenem 21.3 % 20.95 % 50.15 % 16.23 % 13.58 %
Nitrofurantoin 11.7 % 31.15 % 87.87 % 33.78 % 43.48 %
Norfloxacin 59.54 % 31.15 % 49.2 % 36.49 % 30.43 %
Piperacillin Tazobactam 19.9 % 21.78 % 15.47 % 21.52 % 13.58 %
Polymyxin B 0 % 0 % 100 % 0 % 1.23 %
Tobramycin 39.47 % 16.17 % 48.14 % 29.49 % 34.78 %68
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Table 2: Antibiotic resistance pattern of the 45 Multi Drug Resistant  Enterobacteriaceae
Percentage of Resistance Klebsiella(n =22) Ecoli (n =20) Citrobacter (n =2 Proteus (n = 1)
Amikacin 59 % 33% 100 % 100 %
Ampicillin 100 % 100 % 100 % 100 %
Cefazolin 100 % 100 % 100 % 100 %
Cefuroxime 100 % 100 % 100 % 100 %
Cefotaxime 100 % 100 % 100 % 100 %
Cefipime 96% 100 % 100 % 100 %
Ciprofloxacin 91 % 91% 100 % 100 %
Cotrimoxazole 100 % 100 % 100 % 100 %
Colistin 0 % 5% 0 % 100 %
Gentamicin 73 % 67% 100 % 100 %
Imipenem 77 % 67% 100 % 100 %
Meropenem 96 % 95% 50 % 100 %
Nitrofurantoin (urine) 100% 20% 100 % 100 %
Piperacillin Tazobactam 100 % 100 % 100 % 100 %
Polymyxin B 0 % 0% 0 % 100 %
Tobramycin 94 % 73% 100 % 100 %
For  evaluation  of  Modified  Hodge  Test  by  bla KPC
detection using PCR, 45 isolates which were resistant
to both or either Imipenem or Meropenem had been
selected. Of these, 22 were Klebsiella pneumoniae, 20
were Escherichia coli, 2 were Citrobacter species and
1 was Proteus mirabilis). Of the 45 isolates, 43 (95.5
%)  were  resistant  to  Meropenem,  34  (75.5%)  were
resistant to Imipenem and 29 (64.4%) were resistant to
both Imipenem and Meropenem. Modified Hodge Test
was positive in 37 (82.2%) out of 45 isolates and bla
KPC gene was detected in 30 (66.7 %) isolates (Table
3). Of the 30 blaKPC gene positive isolates, MHT was
positive in 27 and negative in 3 isolates. Of the 15
blaKPC gene negative isolates, MHT was positive in 10
(66.6%)  and  negative  in  5  (33.3%)  isolates.
Considering PCR for  bla KPC gene as the gold standard
for  the  detection  of Klebsiella  pneumoniae
Carbapenemase, the sensitivity and specificity of MHT
was calculated using the formula: Sensitivity = a/a+b
and Specificity = d/ c+d. [Where ‘a’ is True Positive
(27), 'b' is False Negative (3), 'c' is False Positive (10)
and’d’ is True Negative (15) ]. In the present study, the
sensitivity of MHT was calculated to be 90 % and the
specificity was 60%. The positive predictive value was
72.97%  and  the  Negative  predictive  value  was
83.33%. Figure 3 shows isolates with positive MHT,
displaying  the  characteristic  clover  leaf  like
indentation and Figure 4 shows the visualization of the
PCR products by gel electrophoresis.
Fig 3: Positive Modified Hodge Test
Fig4:  bla KPC gene  PCR  :  Gel  Electrophoresis
showing positive and negative isolates
Table 3:  Results of MHT and blaKPC gene PCR
Total
Isolates
MHT
(+ve)
Bla KPC
gene(+ve)
MHT  &
bla KPC
gene (+ve)
Klebsiella 22 19 13 11
E coli 20 16 15 14
Citrobacter 2 1 1 1
Proteus 1 1 1 1
Total 45 37 30 2769
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DISCUSSION
In  our  study,  5.2%  of  the  isolates  were  resistant  to
Imipenem, 22.9 % were resistant to Meropenem and
4.42  %  were  resistant  to  both  Imipenem  and
Meropenem. The highest percentage of resistance to
Carbapenems was seen in Klebsiella species, 9.68% to
Imipenem  and  20.9%  to  Meropenem,  followed  by
Escherichia coli, Proteus, Citrobacter and Enterobacter
(Table  1). A  study  by  Ramana  et  al
1 showed  that,
among  the  different Enterobacteriaceae members
tested, Klebsiella spp. showed the highest percentage
of  carbapenem  resistance  at  30%,  whereas Proteus
spp. and Citrobacter spp revealed comparatively low
carbapenem resistance of 17% and 12%, respectively.
The prevalence of carbapenem resistance in our study
was less than that of Ramana et al. Another study by
Parveen  et  al
9 showed  that  45  (43.6%)  of K.
pneumoniae from clinical specimens, were resistant to
meropenem by the disk diffusion test. Among isolates
reported to the National Healthcare Safety Network in
2006–2007 carbapenem resistance was reported in up
to  4.0%  of  Escherichia  coli  and  10.8%  of  K.
pneumoniae isolates that were associated with certain
device-related infections.
10
In the present study, the sensitivity of Modified Hodge
test  was  calculated  to  be  90%.  A  similar  study  by
Anderson  et  al
11 which  had  also  evaluated  the
modified  Hodge  test  for  detection  of  KPC-mediated
resistance  inferred  that  the  test  demonstrated  100%
sensitivity  and  specificity  for  detection  of  KPC
activity. Diana Doyle et al
12 in her study showed that
MHT  had  a  sensitivity  of  98%  for  detecting  KPC
producers  and  93%  for  OXA-48-like  enzyme
producers  but  was  less  than  optimal  for  detecting
MBLs.  The  sensitivity  of  MHT  as  inferred  by  our
study was less than that of the sensitivity of the other 2
studies. This could necessitate changes in the MHT to
make it more sensitive.  A study was carried out by
Pasteren et al
13 using an optimized MHT known as
Pseudomonas  aeruginosa  MHT  (PAE  MHT)  which
demonstrated 100% sensitivity and 98% specificity for
detection of KPC activity without any indeterminate
result. Another study in Greece, showed that Modified
Hodge  test  detected 98%    KPC  producers,  keeping
PCR as the gold standard
[6] In contrast, another study
by D. Girlich et al
5showed that the overall sensitivity
and  specificity  of  the  MHT  was  low  (77.4%  and
38.9%, respectively). In our study too, the specificity
of MHT was low- only 60%. Hatipoglu et al
14 also
state that the MHT has a low specificity. This could be
because  Modified  Hodge  Test  detects  other
carbapenemase enzymes in addition to KPC.
Of the 3 MHT negative isolates, one was positive for
bla KPC gene. Adriane BC et al
15 have also reported
such isolates carrying silent genes. 8 (17.7%) isolates
were  resistant  to  carbapenems,  but  were  MHT
negative.  They  may  have  developed  a  different
resistance mechanism  other  than  carbapenemase
production.
Prevalence of bla KPC gene was found to be 66.67%
among the carbapenem resistant isolates. blaKPC gene
was  not  detected  in  10  MHT  positive  isolates.  This
could indicate the presence of a carbapenemase other
than KP Carbapenemase. Resistance to both imipenem
and meropenem is a strong indicator of carbapenemase
production  rather  resistance  to  either  one  of  the
carbapenems, as this may imply a different resistance
mechanism
CONCLUSION
Modified Hodge Test is a sensitive test for Klebsiella
pneumoniae  Carbapenemase  production.  It is
recommended that  all  isolates  showing  intermediate
sensitivity  or  resistance  pattern  to  carbapenems  be
screened  for the  production of  carbapenemases  by
Modified  Hodge  test,  which will  provide  a  cost-
effective  and  rapid  approach  for  the  detection  of
carbapenemases in Enterobacteriaceae.
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